Vericel Corp. (VCEL)

15.45
NASDAQ : Health Technology
Prev Close 15.50
Day Low/High 15.36 / 15.66
52 Wk Low/High 10.51 / 21.00
Avg Volume 474.60K
Exchange NASDAQ
Shares Outstanding 44.14M
Market Cap 684.12M
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)
Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study Of MACI(TM) Implant

Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study Of MACI(TM) Implant

Poster Presentation at AAOS Annual Meeting Shows Continued Benefit Over Microfracture Bone Marrow Stimulation Procedure

Vericel (VCEL) Stock Gains Today on Better Than Expected Quarter

Vericel (VCEL) Stock Gains Today on Better Than Expected Quarter

Vericel (VCEL) shares are rising after the company beat analysts' net loss and revenue expectations for the period.

TheStreet Quant Rating: D (Sell)